Corporate News     07-Jul-20
Unichem Laboratories receives USFDA approval for Cyclobenzaprine HCI Tablets
Unichem Laboratories has received ANDA approval for its Cyclobenzaprine Hydrochloride Tablets USP, 5 mg, 7.5 mg and 10 mg from the United States Food and Drug Administration (USFDA) to market a generic version of FLEXERIL® (Cyclobenzaprine HCI) Tablets, 5 mg and 10 mg of Janssen Research and Development LLC.

Cyclobenzaprine HCI Tablets are indicated for the treatment as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. The product will be commercialized from Unichem's Goa Plant.

Previous News
  Unichem Laboratories reports standalone net loss of Rs 20.37 crore in the December 2019 quarter
 ( Results - Announcements 03-Feb-20   15:29 )
  Unichem Laboratories to discuss results
 ( Corporate News - 16-Jan-24   11:15 )
  Unichem Laboratories standalone net profit rises 341.78% in the March 2019 quarter
 ( Results - Announcements 25-May-19   15:12 )
  Unichem Laboratories reports consolidated net profit of Rs 2.43 crore in the June 2020 quarter
 ( Results - Announcements 04-Aug-20   17:15 )
  Unichem Laboratories Ltd leads losers in 'A' group
 ( Hot Pursuit - 02-Dec-22   15:00 )
  Unichem Laboratories standalone net profit rises 13.62% in the March 2017 quarter
 ( Results - Announcements 01-Jun-17   17:45 )
  Unichem Laboratories successfully concludes USFDA inspection of Pithampur API facility
 ( Corporate News - 06-Sep-19   11:38 )
  Board of Unichem Laboratories recommends Final Dividend
 ( Corporate News - 25-May-19   14:04 )
  Unichem Laboratories received final ANDA approval for Montelukast Chewable Tablets
 ( Corporate News - 04-Jul-18   13:46 )
  Unichem Laboratories to convene board meeting
 ( Corporate News - 23-Oct-20   14:04 )
  Unichem Lab extends gains after receiving USFDA approval for drug
 ( Hot Pursuit - 10-Mar-16   14:58 )
Other Stories
  Tata Motors records 12% decline in Q2 sales
  01-Oct-24   18:04
  Tata Motors records 15% decline in September sales
  01-Oct-24   17:55
  Man Infra set to launch its highly anticipated Vile Parle project
  01-Oct-24   17:48
  Padam Cotton Yarns to declare Quarterly Result
  01-Oct-24   17:39
  Blueblood Ventures schedules board meeting
  01-Oct-24   17:39
  CRISIL to discuss results
  01-Oct-24   17:39
  Indian Renewable Energy Deve. Agency to convene board meeting
  01-Oct-24   17:39
  Ashapuri Gold Ornament schedules board meeting
  01-Oct-24   17:38
  Bijoy Hans to conduct board meeting
  01-Oct-24   17:38
  RS Software (India) to announce Quarterly Result
  01-Oct-24   17:38
Back Top